Healthcare Services

Needle-Free Drug Delivery Devices Market Growth Outlook Indicating Expansion To $29.91 Billion By 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Needle-Free Drug Delivery Devices Market Compare Between 2026 And 2030?

The market for needle-free drug delivery devices has experienced rapid expansion recently. Projections indicate its value will increase from $18.54 billion in 2025 to $20.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. Historically, this expansion has been driven by factors such as patient needle phobia, the need for safer injection methods, an increase in infectious disease vaccinations, inherent constraints of conventional needle-based techniques, and initial progress in jet injection systems.

The needle-free drug delivery devices market is projected to experience robust expansion over the coming years. This market is anticipated to reach $29.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this growth during the forecast period include the rising incidence of chronic diseases, a greater embrace of self-administration treatments, the spread of telemedicine and remote healthcare, an escalating need for less invasive drug delivery methods, and innovations in microneedle and transdermal technologies. Key trends for the forecast duration involve a heightened preference for pain-free drug administration, increased uptake of at-home drug delivery options, a surge in the application of needle-free devices for children, an increase in self-administered treatments for long-term illnesses, and the proliferation of needle-free vaccine delivery mechanisms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What Important Drivers Are Powering The Needle-Free Drug Delivery Devices Market Growth?

The expanding occurrence of diabetes is anticipated to fuel the progression of the needle-free drug delivery device market in the future. Diabetes manifests as an ongoing health condition characterized by elevated blood glucose levels, resulting from insufficient insulin generation or the body’s poor insulin usage. The global increase in diabetes cases can be attributed to inactive lifestyles, poor eating habits, inherited susceptibility, expanding urban areas, and an aging demographic, further exacerbated by restricted healthcare availability and growing worldwide obesity figures. For diabetes management, needle-free drug delivery devices offer a substitute for traditional injections used in insulin delivery. These devices employ technologies like jet injectors or transdermal patches to administer insulin via the skin without the need for needles, thereby reducing the unease and apprehension frequently associated with injections and improving patient comfort. As an illustration, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the NHS identified more than 549,000 new individuals in England facing a risk of type 2 diabetes development, elevating the overall count of those with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This figure signifies a notable rise when contrasted with the 3,065,825 recorded in 2022, marking an increase of almost 20%. Consequently, the rising occurrence of diabetes is stimulating the expansion of the needle-free drug delivery device market.

Which Segment Groups Define The Needle-Free Drug Delivery Devices Market Landscape?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches

What Trends Are Affecting The Needle-Free Drug Delivery Devices Market Dynamics?

Major companies engaged in the necrotizing fasciitis market are primarily focused on developing innovative therapies, such as antibiotics and immunotherapies, to target biologics and advanced wound care solutions. Antibiotics are medications designed to kill or inhibit the growth of bacteria, while immunotherapies involve treatments that strengthen or modify the body’s immune system to combat infections or diseases. For instance, in March 2025, Altru Health System, a US-based nonprofit physician-led healthcare organization, introduced Hyperbaric Oxygen Therapy (HBO) to boost wound healing and support the recovery of patients with chronic or challenging-to-heal conditions. This therapy delivers 100% oxygen in a pressurized chamber, which improves tissue oxygenation and encourages the body’s natural healing processes. It is intended for treating conditions such as diabetic foot ulcers, radiation-induced tissue damage, compromised skin grafts, and severe infections, serving as a non-invasive supplement to conventional medical treatment.

Which Firms Are Competing In The Needle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are 3M Company, Medtronic plc, Novo Nordisk AS, Becton Dickinson and Company, Insulet Corporation, MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG, Bayer AG, Antares Pharma Inc., Inovio Pharmaceuticals Inc.

Access The Complete Needle-Free Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Region Leads The Needle-Free Drug Delivery Devices Market By Size?

North America was the largest region in the needle-free drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Needle-Free Drug Delivery Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2026, By The Business Research Company

Rotavirus Prophylaxis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

Appendicitis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/appendicitis-treatment-global-market-report

Automotive Fascia Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-fascia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795